INBX |
Inhibrx Biosciences, Inc. |
Aug 28, 2024 |
1 |
$140K |
4 |
Aug 30, 2024 |
Director |
INBX |
Inhibrx, Inc. |
May 30, 2024 |
5 |
$0 |
4 |
May 30, 2024 |
Director |
INXB |
Inhibrx Biosciences, Inc. |
May 30, 2024 |
1 |
$0 |
4 |
May 30, 2024 |
Director |
INXB |
Inhibrx Biosciences, Inc. |
May 24, 2024 |
0 |
$0 |
3 |
May 24, 2024 |
Director |
INBX |
Inhibrx, Inc. |
May 25, 2023 |
1 |
$0 |
4 |
May 30, 2023 |
Director |
HRTX |
HERON THERAPEUTICS, INC. /DE/ |
Apr 13, 2023 |
5 |
-$4.08K |
4 |
Apr 17, 2023 |
EVP, Drug Development |
HRTX |
HERON THERAPEUTICS, INC. /DE/ |
Jan 18, 2023 |
1 |
$0 |
4 |
Jan 20, 2023 |
EVP, Drug Development, Director |
HRTX |
HERON THERAPEUTICS, INC. /DE/ |
Jan 13, 2023 |
6 |
-$962 |
4 |
Jan 17, 2023 |
EVP, Drug Development, Director |
HRTX |
HERON THERAPEUTICS, INC. /DE/ |
Oct 13, 2022 |
5 |
-$7.57K |
4 |
Oct 17, 2022 |
EVP, Drug Development, Director |
HRTX |
HERON THERAPEUTICS, INC. /DE/ |
Jul 25, 2022 |
1 |
$0 |
4 |
Jul 27, 2022 |
EVP, Drug Development, Director |
HRTX |
HERON THERAPEUTICS, INC. /DE/ |
Jul 13, 2022 |
5 |
-$6.06K |
4 |
Jul 15, 2022 |
EVP, Drug Development, Director |
INBX |
Inhibrx, Inc. |
May 25, 2022 |
1 |
$0 |
4 |
May 26, 2022 |
Director |
HRTX |
HERON THERAPEUTICS, INC. /DE/ |
May 3, 2022 |
2 |
-$1.38K |
4 |
May 4, 2022 |
EVP, Drug Development, Director |
HRTX |
HERON THERAPEUTICS, INC. /DE/ |
Apr 13, 2022 |
5 |
-$12.2K |
4 |
Apr 15, 2022 |
EVP, Drug Development, Director |
HRTX |
HERON THERAPEUTICS, INC. /DE/ |
Jan 13, 2022 |
5 |
-$16.7K |
4 |
Jan 14, 2022 |
EVP, Drug Development, Director |
HRTX |
HERON THERAPEUTICS, INC. /DE/ |
Oct 13, 2021 |
5 |
-$4.57K |
4 |
Oct 15, 2021 |
EVP, Drug Development, Director |
HRTX |
HERON THERAPEUTICS, INC. /DE/ |
Jul 13, 2021 |
3 |
-$5.84K |
4 |
Jul 15, 2021 |
EVP, Drug Development, Director |
INBX |
Inhibrx, Inc. |
Jun 7, 2021 |
1 |
$0 |
4 |
Jun 8, 2021 |
Director |